No, circumcision doesn’t cause autism
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. A big round of applause to STAT’s Lev Facher, who won a Loeb Award last
Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in N.C.
Auto-injector specialist Ypsomed is hopping on the United States manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the first
Jay Shetty and his health advice are everywhere. It’s by design
Looking directly at the camera with alert, empathetic eyes, Jay Shetty asks: “Do you feel like you try and eat healthy, but you’re constantly tired by 3 p.m.? Or maybe you’re trying
Future solitude
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03251-w Alone but not lonely.
Rebuilding Gaza: don’t sideline Palestinian scientists, say experts
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03324-w Researchers warn against ‘top down’ solutions as ceasefire is agreed in the first phase of a peace deal.
Portable muon beam could accelerate archaeology scans
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03245-8 Laser plasma device could be light enough to be used on the field.
STAT+: Key GOP lawmaker tones down rhetoric on medical care for immigrants
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Three
AstraZeneca kicks off construction of $4.5B API plant in Virginia
AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic development package for the
First gene-edited pig liver transplanted into a living person
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. A STAT editor spotted somebody yesterday wearing a t-shirt that read: “I Tylenol.” That
Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.
Lupin expects to invest a combined $250 million—covering R&D, infrastructure and capital expenditures over five years—to build a new pharmaceutical production plant in Coral Springs, Florida. The site will focus on the